GemPharmatech
Mark (Wenchun) Chen is currently serving as the Area Sales and Business Development Manager at GemPharmatech since July 2024. Prior roles include Business Development Manager at WuXi Biologics from February 2023 to June 2024, and a Data Scientist Fellow at Techlent from September 2022 to February 2023, where Mark built a prediction engine to detect Medicare provider fraud. Previously, as a Sr. Staff Scientist at BioLegend, Mark led the Molecular Cloning team, optimizing processes and facilitating the successful delivery of over 180 recombinant proteins and antibodies. Mark's academic background includes a Ph.D. in Biomedicine from The Julius Maximilians University of Würzburg and a Master's degree in Physiology from East China Normal University.
This person is not in any offices
GemPharmatech
1 followers
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.